Business
Bio Spectrum
Revvity introduces new IVD reference standards for oncology testing
Revvity, Inc. has announced the launch of three Mimix reference standards for IVD use, designed for monitoring of next-generation sequencing (NGS) or droplet digital polymerase chain reacting (ddPCR) assays designed to detect somatic mutations in genomic DNA (gDNA) from human samples for IVD use.
1 min |
August 2025
Bio Spectrum
US FDA determines safety and effectiveness of immunotherapies
The US Food and Drug Administration (FDA) has eliminated the Risk Evaluation and Mitigation Strategies (REMS) for currently approved BCMA- and CD19-directed autologous chimeric antigen receptor CAR T cell immunotherapies.
1 min |
August 2025
Bio Spectrum
Pioneering research to develop all-in-one vaccine against deadly diseases
Scientists at Denmark's AdaptVac will lead the development of a new vaccine that could provide all-in-one protection against multiple deadly viruses including Ebolavirus Zaire, Sudan Ebolavirus and Marburg, all of which cause frequent unpredictable outbreaks in regions of Africa, with significant health and societal impacts and fatality rates of up to 90 per cent.
1 min |
August 2025
Bio Spectrum
IISc develops simple sensor for liver cancer detection
Researchers at the Indian Institute of Science (IISc), Bengaluru have developed a unique luminescent probe that uses terbium, a rare earth metal, to sense the presence of an enzyme called -glucuronidase, which can potentially aid in the detection of liver cancer.
1 min |
August 2025
Bio Spectrum
Punjab launches Data Intelligence & Technical Support Unit to strengthen fight against drugs
In a decisive step towards combating drugs and substance abuse, the Government of Punjab has launched the Data Intelligence and Technical Support Unit (DITSU) - a pioneering initiative under its flagship campaign Yudh Nasheyan Virudh (War Against Drugs).
1 min |
August 2025
Bio Spectrum
Piramal Pharma Solutions breaks ground on $90 M expansion plan in US
Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organisation (CDMO) and part of Mumbai-based Piramal Pharma Ltd., recently announced a $90 million investment plan to expand two of its US facilities, which are critical to its integrated offering.
1 min |
August 2025
Bio Spectrum
OMRON and Tricog Health launch KeeboHealth to combat India's cardiac crisis
OMRON Healthcare, a global leader in innovative home health monitoring solutions, has expanded its collaboration with Tricog Health, an AI-driven cardiac care company, to launch KeeboHealthan advanced connected health platform designed to transform remote cardiac care and accelerate progress toward OMRON's ambitious 'Going for Zero' vision - a world with zero cardiovascular events.
1 min |
August 2025
Bio Spectrum
World-first AI system to warn of NHS patient safety concerns
Patients will receive better care owing to a world-first artificial intelligence (AI) early warning system being developed to automatically identify safety concerns across the National Health Service (NHS) in England, helping stop failures before they escalate.
1 min |
August 2025
Bio Spectrum
CeNS designs pocketsized sensor to detect health threats in air
Scientists from Centre for Nano and Soft Matter Sciences (CeNS), Bengaluru, an autonomous institute of Department of Science and Technology (DST), have fabricated a sensor by combining two metal oxides-nickel oxide (NiO) and neodymium nickelate (NdNiO3), through a simple synthesis process.
1 min |
August 2025
Bio Spectrum
Bharat Biotech to reduce cost of malaria vaccine RTS,S to less than $5
Hyderabad-based Bharat Biotech International Limited (BBIL) and GSK plc have announced their commitment to Gavi, the Vaccine Alliance (Gavi), in the continued roll out of the world's first malaria vaccine.
1 min |
August 2025
Bio Spectrum
GTT Data AI Accelerator Network to empower startups in healthcare and life sciences
GTT Data Solutions, a BSE-listed technology enabler known for its Dual Intelligence framework that blends human expertise with advanced artificial intelligence (AI), has launched GAIN (GTT Data AI Accelerator Network), a platform designed to support over 100 AI startups across industries, including a sharp focus on healthcare and life sciences.
1 min |
August 2025
Bio Spectrum
World leaders recommit to immunisation amid global funding shortfall
At the recently held Global Summit: Health and Prosperity through Immunisation in Brussels, world leaders have pledged support for Gavi, the Vaccine Alliance, leading to a total of more than $9 billion secured against a targeted $11.9 billion budget for its next five-year strategic period from 2026 to 2030 (Gavi 6.0).
1 min |
August 2025
Bio Spectrum
How Are Indian Institutions Advancing Organoid Research?
For Indian businesses, the combination of robotics and artificial intelligence with organoid technology offers enormous potential for creating automated, scalable organoid production systems.
2 min |
August 2025
Bio Spectrum
Xcell Biosciences collaborates with Thermo Fisher to advance next generation of cell therapies
Xcell Biosciences, a US-based instrumentation company focused on cell and gene therapy applications, has announced a strategic collaboration with Thermo Fisher Scientific Inc., the world leader in serving science, to advance research in regulatory T cells (Tregs) and tumour-infiltrating lymphocytes (TILs).
1 min |
August 2025
Bio Spectrum
INSA Women Associates names Dr Prajakta Dandekar Jain as Founding Member
The Institute of Chemical Technology (ICT), Mumbai, has announced the selection of Dr Prajakta Dandekar Jain, UGC Assistant Professor at the Department of Pharmaceutical Sciences and Technology, as a Founding Member of the newly constituted INSA Women Associates (IWA) by the Indian National Science Academy (INSA), New Delhi.
1 min |
August 2025
Bio Spectrum
Deadly Silence: India's Negligent Pharma Manufacturing Units
Indian pharma manufacturing units are a ticking time bomb. Inflammable chemicals that require special handling are often callously used by ignorant workers leading to reactions, reactor blasts and deaths. Above it, ill-designed setups and less knowledge of hardware and software are taking a toll on the industry. Showing a lackadaisical attitude towards the way manufacturing sites are being operated, Indian pharma companies are at the receiving end of various domestic and global regulators. Overlooking safety issues will lead to more catastrophic events.
7 min |
August 2025
Bio Spectrum
Rubicon Research completes acquisition of Alkem's Pithampur unit for Rs 149 Cr
Rubicon Research has completed the acquisition of Alkem Laboratories’ formulations manufacturing facility in Pithampur, Madhya Pradesh in an all-cash deal for Rs 149 crore.
1 min |
August 2025
Bio Spectrum
Digital Personal Data Protection Act (DPDPA) – A Wake-Up Call for IVF Clinics
With the introduction of the Digital Personal Data Protection Act, 2023 (DPDPA), questions are being raised about how India's earlier medical laws handle patient data and privacy.
3 min |
August 2025
Bio Spectrum
Waters launches Xevo TQ Absolute XR Mass Spectrometer
Waters Corporation has announced the launch of the Xevo TQ Absolute XR Mass Spectrometer, the company's most sensitive, robust, and reliable benchtop tandem quadrupole.
1 min |
August 2025
Bio Spectrum
Next-generation surgical robotics stand poised for global revolution
The adoption of robot-assisted surgery has increased significantly in the past decade as opportunities for performing minimally invasive procedures have multiplied.
5 min |
August 2025
Bio Spectrum
Quantum Sensing and Healthcare: Charting India's Next Frontier
Quantum sensing can revolutionise healthcare by enabling early disease detection, precise diagnostics, and customized treatment plans. It detects subtle changes in fields, improving diagnoses for various diseases.
4 min |
August 2025
Bio Spectrum
Accelerated Reliance on Digital Animal Replacement Tech
While Europe is talking about non-animal replacement tests to be used for drug development and research purposes, US FDA is acting upon it with a detailed roadmap aimed at rapidly reducing animal testing in preclinical safety assessments. These developments clearly provide huge opportunities for global companies that are developing alternative methods such as organoids, 3D bioprinting, digital animal replacement technology, computer simulation, to name a few. But where does India stand in this regard, and how skilled are we to make this shift?
4 min |
August 2025
Bio Spectrum
How Can Labs Reduce Their Energy Consumption?
Research labs can concentrate on innovation by collaborating with infrastructure providers, leaving waste, water, and energy management to professionals.
2 min |
August 2025
Bio Spectrum
LogicFlo AI gets $2.7 M to scale AI agent workforce across global life sciences enterprises
Chennai-based startup LogicFlo AI, an artificial intelligence (AI) platform designed specifically for the life sciences sector, has raised $2.7 million in a seed round led by Lightspeed, with participation from leading healthcare and enterprise AI investors.
1 min |
August 2025
Bio Spectrum
Why the New Schedule M Is a Game Changer for Indian Pharma and How the Industry Is Adapting
The Indian pharmaceutical industry stands at a pivotal moment. With the government's notification of the revised Schedule M in January 2024, the sector is undergoing a structural and cultural transformation. The updated regulations, which bring India’s Good Manufacturing Practices (GMP) in line with global standards, are not just compliance mandates, they represent a paradigm shift towards consistent quality, operational excellence, and global competitiveness.
4 min |
BioSpectrum India July 2025
Bio Spectrum
“There is a huge gap in corporate engagement and government procurement of innovative products within Telangana”
According to the world’s leading real estate consulting firm, CNRE’s latest report, ‘Global Life Sciences Atlas’, Hyderabad has emerged as a prominent global centre of life sciences manufacturing activity in India. This positions Telangana to play a defining role in shaping the next decade of biotech innovation and entrepreneurship. In alignment with this development, Hyderabad-based Atal Incubation Centre (AIC), hosted in one of the premier research institutes, CSIR-Centre for Cellular and Molecular Biology (CCMB), seeks unique schemes and proposals from the government to strengthen biotech entrepreneurship in the state. Dr N. Madhusudhana Rao, Chief Executive Officer, AIC-CCMB, spoke with BioSpectrum India, highlighting the dynamic growth trajectory of the biotech innovation ecosystem in Telangana. Edited excerpts:
4 min |
BioSpectrum India July 2025
Bio Spectrum
Qiagen expands portfolio for minimal residual disease testing in oncology
Netherlands-based holding company Qiagen N.V. has announced the expansion of its oncology diagnostics portfolio with two strategic partnerships to advance the use of minimal residual disease (MRD) testing in clinical trials to support pharma co-development projects for companion diagnostics.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Thermo Fisher Scientific launches new Spectral Flow Cytometer
Thermo Fisher Scientific Inc. has launched the spectralenabled Invitrogen Attune Xenith Flow Cytometer, allowing immunology and immuno-oncology researchers to automate and streamline workflows to obtain more detailed and accurate insights from critical cellular samples.
1 min |
BioSpectrum India July 2025
Bio Spectrum
NIT Rourkela designs labelfree biosensor for affordable breast cancer diagnosis
Researchers at the National Institute of Technology (NIT) Rourkela, Odisha have investigated a novel semiconductor devicebased biosensor that can identify breast cancer cells without the need for complicated or expensive laboratory procedures.
1 min |
BioSpectrum India July 2025
Bio Spectrum
Africa CDC, WHO, and RKI expand unique partnership to strengthen collaborative surveillance
The World Health Organization (WHO), Africa Centres for Disease Control and Prevention (Africa CDC) and the Robert Koch Institute (RKI) have announced the expansion of the successful Health Security Partnership to Strengthen Disease Surveillance in Africa (HSPA) to seven countries on the continent.
1 min |